P

Inventor

FENG JUN

US144 patents
⚠️ This page may combine multiple inventors who share the name “FENG JUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ARAXES PHARMA LLC

31 patents
US9926267B2Mar 27, 2018

Covalent inhibitors of K-Ras G12C

ARAXES PHARMA LLC38 citations98
US9840516B2Dec 12, 2017

Substituted quinazolines as inhibitors of KRAS G12C

ARAXES PHARMA LLC73 citations98
US9227978B2Jan 5, 2016

Covalent inhibitors of Kras G12C

ARAXES PHARMA LLC47 citations98
US10745385B2Aug 18, 2020

Covalent inhibitors of KRAS

ARAXES PHARMA LLC17 citations94
US10736897B2Aug 11, 2020

Compounds and methods of use thereof for treatment of cancer

ARAXES PHARMA LLC28 citations94
US10428064B2Oct 1, 2019

Fused-tricyclic inhibitors of KRAS and methods of use thereof

ARAXES PHARMA LLC27 citations94
US10414757B2Sep 17, 2019

2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof

ARAXES PHARMA LLC33 citations94
US10377743B2Aug 13, 2019

Inhibitors of RAS and methods of use thereof

ARAXES PHARMA LLC29 citations94
US10370386B2Aug 6, 2019

Substituted quinolines as inhibitors of KRAS G12C

ARAXES PHARMA LLC33 citations94
US10351550B2Jul 16, 2019

Substituted quinazoline compounds and methods of use thereof

ARAXES PHARMA LLC27 citations94
US10280172B2May 7, 2019

Inhibitors of KRAS G12C mutant proteins

ARAXES PHARMA LLC34 citations94
US10273207B2Apr 30, 2019

Covalent inhibitors of kras G12C

ARAXES PHARMA LLC24 citations94
US10246424B2Apr 2, 2019

Substituted quinazoline compounds and methods of use thereof

ARAXES PHARMA LLC36 citations94
US10144724B2Dec 4, 2018

Substituted quinazoline compounds and methods of use thereof

ARAXES PHARMA LLC44 citations94
US9862701B2Jan 9, 2018

Inhibitors of KRAS G12C mutant proteins

ARAXES PHARMA LLC45 citations94
US9745319B2Aug 29, 2017

Irreversible covalent inhibitors of the GTPase K-Ras G12C

ARAXES PHARMA LLC43 citations94
US10975071B2Apr 13, 2021

Inhibitors of KRAS G12C mutant proteins

ARAXES PHARMA LLC9 citations86
US10927125B2Feb 23, 2021

Substituted cinnolines as inhibitors of KRAS G12C

ARAXES PHARMA LLC11 citations86
US10919850B2Feb 16, 2021

Covalent inhibitors of KRas G12C

ARAXES PHARMA LLC9 citations86
US10882847B2Jan 5, 2021

Inhibitors of KRAS G12C mutant proteins

ARAXES PHARMA LLC11 citations86
US10875842B2Dec 29, 2020

Inhibitors of KRAS G12C mutant proteins

ARAXES PHARMA LLC11 citations86
US10858343B2Dec 8, 2020

Inhibitors of KRAS G12C mutant proteins

ARAXES PHARMA LLC11 citations86
US10829458B2Nov 10, 2020

Substituted quinazoline compounds and methods of use thereof

ARAXES PHARMA LLC13 citations86
US10730867B2Aug 4, 2020

Inhibitors of KRAS G12C mutant proteins

ARAXES PHARMA LLC15 citations86
US10723738B2Jul 28, 2020

Inhibitors of KRAS G12C mutant proteins

ARAXES PHARMA LLC15 citations86
US10689356B2Jun 23, 2020

Inhibitors of KRAS G12C mutant proteins

ARAXES PHARMA LLC16 citations86
US10647703B2May 12, 2020

Inhibitors of KRAS G12C mutant proteins

ARAXES PHARMA LLC18 citations86
US11059819B2Jul 13, 2021

Fused hetero-hetero bicyclic compounds and methods of use thereof

ARAXES PHARMA LLC8 citations84
US11021470B2Jun 1, 2021

2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof

ARAXES PHARMA LLC8 citations84
US10822312B2Nov 3, 2020

Substituted quinazoline compounds and methods of use

ARAXES PHARMA LLC10 citations84
US10011600B2Jul 3, 2018

Methods and compositions for inhibition of Ras

ARAXES PHARMA LLC12 citations84

HECHT THOMAS R

4 patents

TAKEDA PHARMACEUTICAL

4 patents

KURA ONCOLOGY INC

3 patents

FENG JUN

2 patents

AUTOMATIC BAR CONTROLS INC

2 patents

(unassigned)

1 patent

ANTAYA TIMOTHY A

1 patent

NOVO NORDISK AS

1 patent

UNIV MICHIGAN REGENTS

1 patent

Showing the top 50 of 144 patents by PatentIndex Score.